Rebecca Mosig
- Cancer Research top 10%
- Molecular Biology
- Oncology
- Rheumatology top 10%
- Genetics
- Co-authors
- John A. MartignettiMarc GlucksmanJames D. WylieA. Al AqeelMone ZaidiPaolo BiancoSuneel ApteOonagh Dowling
- Topics
- Protease and Inhibitor Mechanisms (5 papers)Ovarian cancer diagnosis and treatment (4 papers)IL-33, ST2, and ILC Pathways (3 papers)
- Cited by
- Cancer ResearchRheumatologyOncology
- Partner nations
- United StatesItalyBelgium
In The Last Decade
Rebecca Mosig
21 papers receiving 487 citations
Peers
Comparison fields: 5 of 71
- Cancer Research 219
- Molecular Biology 196
- Oncology 170
- Rheumatology 108
- Genetics 101
Countries citing papers authored by Rebecca Mosig
This map shows the geographic impact of Rebecca Mosig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rebecca Mosig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rebecca Mosig more than expected).
Fields of papers citing papers by Rebecca Mosig
This network shows the impact of papers produced by Rebecca Mosig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rebecca Mosig. The network helps show where Rebecca Mosig may publish in the future.
Co-authorship network of co-authors of Rebecca Mosig
This figure shows the co-authorship network connecting the top 25 collaborators of Rebecca Mosig. A scholar is included among the top collaborators of Rebecca Mosig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rebecca Mosig. Rebecca Mosig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 2 | |
| 7 | 6 | |
| 8 | 8 | |
| 9 | 9 | |
| 10 | 23 | |
| 11 | 23 | |
| 12 | 4 | |
| 13 | 22 | |
| 14 | 18 | |
| 15 | 43 | |
| 16 | 20 | |
| 17 | 18 | |
| 18 | 37 | |
| 19 | 172 | |
| 20 | Polymorphism in the thymidylate synthase promoter enhancer region modifies the risk and survival of colorectal cancer. | 78 |
About Rebecca Mosig
Rebecca Mosig is a scholar working on Reproductive Medicine, Cancer Research and Immunology, having authored 22 papers that have together received 491 indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (5 papers), Ovarian cancer diagnosis and treatment (4 papers) and IL-33, ST2, and ILC Pathways (3 papers). The work is most often cited by research in Cancer Research (219 citations), Rheumatology (108 citations) and Oncology (170 citations). Rebecca Mosig has collaborated with scholars based in United States, Italy and Belgium. Frequent co-authors include John A. Martignetti, Marc Glucksman, James D. Wylie, A. Al Aqeel, Mone Zaidi, Paolo Bianco, Suneel Apte, Oonagh Dowling, Joseph A. Madri and Analisa DiFeo. Their work appears in journals such as Genes & Development, The American Journal of Human Genetics and Human Molecular Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.